>
Budget Steak Tastes Like $100 After This One Trick
OPEC Fractures, the Draft Returns, and the Age of Consequences Begins
China Confirms Boeing Jet Deal, Agrees To Cut Select Levies & Expand Agri Trade
Here's Where Wealth Is Moving In America
US To Develop Small Modular Nuclear Reactors For Commercial Shipping
New York Mandates Kill Switch and Surveillance Software in Your 3D Printer ...
Cameco Sees As Many As 20 AP1000 Nuclear Reactors On The Horizon
His grandparents had heart disease.
At 11, Laurent Simons decided he wanted to fight aging.
Mayo Clinic's AI Can Detect Pancreatic Cancer up to 3 Years Before Diagnosis–When Treatment...
A multi-terrain robot from China is going viral, not because of raw speed or power...
The World's Biggest Fusion Reactor Just Hit A Milestone
Wow. Researchers just built an AI that can control your body...
Google Chrome silently installs a 4 GB AI model on your device without consent
The $5 Battery That Never Dies - Edison Buried This 100 Years Ago

Patient Number Two was born to first-time parents, late 20s, white. The pregnancy was normal and the birth uncomplicated. But after a few months, it became clear something was wrong. The child had ear infection after ear infection and trouble breathing at night. He was small for his age, and by his fifth birthday, still hadn't spoken. He started having seizures. Brain MRIs, molecular analyses, basic genetic testing, scores of doctors; nothing turned up answers. With no further options, in 2015 his family decided to sequence their exomes—the portion of the genome that codes for proteins—to see if he had inherited a genetic disorder from his parents. A single variant showed up: ARID1B.
The mutation suggested he had a disease called Coffin-Siris syndrome. But Patient Number Two didn't have that disease's typical symptoms, like sparse scalp hair and incomplete pinky fingers. So, doctors, including Karen Gripp, who met with Two's family to discuss the exome results, hadn't really considered it. Gripp was doubly surprised when she uploaded a photo of Two's face to Face2Gene. The app, developed by the same programmers who taught Facebook to find your face in your friend's photos, conducted millions of tiny calculations in rapid succession—how much slant in the eye? How narrow is that eyelid fissure? How low are the ears? Quantified, computed, and ranked to suggest the most probable syndromes associated with the facial phenotype. There's even a heat map overlay on the photo that shows which the features are the most indicative match.
"In hindsight it was all clear to me," says Gripp, who is chief of the Division of Medical Genetics at A.I. duPont Hospital for Children in Delaware, and had been seeing the patient for years. "But it hadn't been clear to anyone before." What had taken Patient Number Two's doctors 16 years to find took Face2Gene just a few minutes.

FDNA
Face2Gene takes advantage of the fact that so many genetic conditions have a tell-tale "face"—a unique constellation of features that can provide clues to a potential diagnosis. It is just one of several new technologies taking advantage of how quickly modern computers can analyze, sort, and find patterns across huge reams of data. They are built in fields of artificial intelligence known as deep learning and neural nets—among the most promising to deliver AI's 50-year old promise to revolutionize medicine by recognizing and diagnosing disease.
Genetic syndromes aren't the only diagnoses that could get help from machine learning. The RightEye GeoPref Autism Test can identify the early stages of autism in infants as young as 12 months—the crucial stages where early intervention can make a big difference.